Advances in the Diagnosis and Treatment of Brain Damage
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Brain Injury".
Deadline for manuscript submissions: closed (20 February 2024) | Viewed by 12213
Special Issue Editor
Interests: neuroimmunology; multiple sclerosis; neuromyelitis optica spectrum disease; B cells; oncoimmunology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
There are multiple pathophysiological conditions, including neurovascular diseases, neuro-trauma, infectious diseases, neurodegenerative diseases, tumors, and neuroinflammation, which lead to brain damage and are associated with various clinical symptoms. Although huge advances with regards to molecular diagnostics and MRI have been made during clinical work-up, differential diagnoses might still be challenging, it is often difficult to predict future disease courses, and the clinical presentation is not always reflected by corresponding brain lesions on MRI. Despite growing treatment options that address direct pathophysiological mechanisms, the brain is a highly complex organ that is still challenging to treat and multiple diseases can only be treated symptomatically.
With this Special Issue, we hope to encourage submissions that discuss the current state-of-the-art of both clinical and radiological features of brain damage, molecular aspects (such as serum or CSF markers in different diseases), newly evolving diagnostic tools, and therapies (such as neuro-regenerative treatments), as well as address challenges and ongoing controversies.
Dr. Markus C. Kowarik
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- brain damage
- clinical presentation
- MRI
- clinical radiological correlation
- CNS biomarkers
- CNS-specific treatments
- neurodegenerative treatments
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.